Cécile Dupont Redon

Cécile Dupont Redon serves as the Chief Executive Officer at BrightHeart since November 2022 and is a Partner at Sofinnova Partners, where involvement spans multiple roles in the MD Start program since July 2019. At Sofinnova, the focus is on early-stage investments in Life Sciences, contributing to the financing and development of nearly 500 companies over four decades. In addition to these roles, Cécile holds board membership at Endoron Medical, which develops innovative medical solutions for abdominal aortic aneurysms, and previously served as President of HEPTA Medical. Cécile's extensive career includes positions such as COO of Gradient Denervation Technologies and Senior Analyst at MD Start, complemented by various clinical and regulatory roles at companies like SafeHeal and DAMAE Medical. Educational qualifications include a degree in biomedical engineering from Université de Technologie de Compiègne and executive training in corporate finance from HEC Paris.